Adam K, Vavatsi N, Mytilineos J, Kouidou S, Polymenidis Z, Trakatellis A, Opelz G
Immunology Department, Thessaloniki, Greece.
Transpl Int. 1994;7 Suppl 1:S522-6. doi: 10.1111/j.1432-2277.1994.tb01434.x.
The serological identification of HLA class II alleles is often doubtful. Since accurate HLA typing is essential for the matching of donor-recipient pairs in allogeneic transplantation, an effort was made to establish DNA restriction fragment length polymorphism (RFLP) typing and to assess the correlation between the serological and RFLP techniques in the population of Northern Greece. One hundred and two healthy individuals (204 HLA-DR alleles) from Northern Greece were HLA-DR, DQ typed with both the microcytotoxicity and the Taq I RFLP method, using three exon-specific probes. DNA-RFLP typing revealed (1) concordant results with serology in 69.9% (142/204) of the alleles and (2) at least one HLA-DR allele discrepant to serology in 30.4% (62/204) of the alleles. Incorrect serological DR types (weak reactions or inability to distinguish between two alleles with a common epitope) were identified in 54 alleles (26.5%), while 3.9% (8/204) of serological "blank" alleles turned out to be definable alleles by RFPL. Of the individuals tested, 10.8% (11/102) were DR-homozygous by RFLP. This comparison of results obtained by serology and RFLP demonstrated the necessity of the clinical application of DNA typing, especially for organ transplantation where accurate HLA typing has an important influence on graft survival.
HLA Ⅱ类等位基因的血清学鉴定结果常常难以确定。由于准确的 HLA 分型对于同种异体移植中供受者配对至关重要,因此我们致力于建立 DNA 限制性片段长度多态性(RFLP)分型,并评估希腊北部人群中血清学和 RFLP 技术之间的相关性。我们使用三种外显子特异性探针,采用微量细胞毒性和 Taq I RFLP 方法对来自希腊北部的 102 名健康个体(204 个 HLA-DR 等位基因)进行了 HLA-DR、DQ 分型。DNA-RFLP 分型显示:(1)69.9%(142/204)的等位基因与血清学结果一致;(2)30.4%(62/204)的等位基因中至少有一个 HLA-DR 等位基因与血清学结果不一致。在 54 个等位基因(26.5%)中鉴定出血清学 DR 分型错误(弱反应或无法区分具有共同表位的两个等位基因),而 3.9%(8/204)的血清学“空白”等位基因通过 RFPL 证明是可定义的等位基因。在接受检测的个体中,10.8%(11/102)通过 RFLP 检测为 DR 纯合子。血清学和 RFLP 结果的比较表明了 DNA 分型临床应用的必要性,特别是对于器官移植,准确的 HLA 分型对移植物存活有重要影响。